Garodia Chemicals Ltd Reports Profit Post NCLT Restructuring

₹3.92 crore Profit | ₹4.06 crore Revenue

Reader Takeaway: Debt settlement income drives profit; monitor core operations and equity.

What just happened

Garodia Chemicals Ltd has announced its audited financial results for the year ended March 31, 2026, reporting a profit after tax of ₹3.92 crore. This marks a significant turnaround from a loss of ₹0.21 crore in the previous financial year. The company's total revenue was reported at ₹4.06 crore, primarily boosted by 'Other income' of the same amount arising from loan settlements under the National Company Law Tribunal (NCLT)-approved Base Resolution Plan.

Why this matters

This filing is crucial as it signals the completion of a major corporate restructuring for Garodia Chemicals. The shift from loss to profit, driven by debt settlement, indicates a de-leveraging of the balance sheet. For investors, it signifies a new operational phase post-NCLT intervention, though the sustainability of profitability hinges on core business performance rather than one-time gains.

The backstory

Garodia Chemicals has been undergoing financial distress, leading to its resolution under the NCLT framework. The Base Resolution Plan involved significant changes to the company's capital structure. This included a capital reduction and the allotment of new shares to a new promoter.

What changes now

The company's paid-up equity share capital has been drastically reduced and then increased with new allotments. Specifically, paid-up equity share capital was reduced from 72,00,200 shares (₹10 face value) to 2,63,157 shares (₹1 face value), with the balance offset against accumulated losses. Subsequently, 50,00,000 new equity shares of ₹1 each were allotted to the new promoter, resulting in a revised paid-up equity capital of ₹0.05 crore. Earnings per share (EPS) figures have been restated to reflect these changes.

Risks to watch

While the debt settlement is a positive step, the primary risk is the reliance on one-time income. The company's 'Other Equity' remains negative at ₹-0.81 crore, indicating that the balance sheet still shows signs of financial strain. Investors must monitor the company's ability to generate sustainable revenue from its core operations and improve its equity position.

Peer comparison

Information on specific peers for Garodia Chemicals was not provided in the filing. However, companies undergoing NCLT restructuring often face challenges in restoring core operations and profitability post-resolution. Success typically depends on management's ability to revive business and attract further investment.

Context metrics (time-bound)

• Profit/Loss: FY26: ₹3.92 crore profit vs. FY25: ₹0.21 crore loss.
• Revenue: FY26: ₹4.06 crore (driven by settlement income).
• Other Equity: FY26: ₹-0.81 crore vs. FY25: ₹-11.90 crore.
• Non-current borrowings: FY26: ₹0.32 crore vs. FY25: ₹4.82 crore.
• Net cash from operations: FY26: ₹4.00 crore.

What to track next

Investors should closely track Garodia Chemicals' subsequent quarterly results to assess the sustainability of its core business operations. Improvement in 'Other Equity' and consistent revenue growth from operational activities will be key indicators of the company's recovery and future prospects.